Featured Research

Stroke treatment, outcomes improve with new initiative

Date:

April 22, 2014

Source:

University of California, Los Angeles (UCLA), Health Sciences

Summary:

A study demonstrated that hospitals participating in a national quality-improvement program have markedly increased the speed with which they treat stroke patients with the clot-busting drug. This speedier treatment was accompanied by reduced mortality, fewer treatment complications and a greater likelihood that patients would go home after leaving the hospital instead of being referred to a skilled nursing facility.

Share This

Administering a clot-dissolving drug to stroke victims quickly -- ideally within the first 60 minutes after they arrive at a hospital emergency room -- is crucial to saving their lives, preserving their brain function and reducing disability.

Related Articles

Given intravenously, tPA (tissue plasminogen activator) is currently the only Food and Drug Administration-approved therapy shown to improve outcomes for patients suffering acute ischemic stroke, which affects some 800,000 Americans annually.

Now, a UCLA-led study demonstrates that hospitals participating in the "Target: Stroke" national quality-improvement program have markedly increased the speed with which they treat stroke patients with tPA. Researchers looked at more than 1,000 hospitals participating in the initiative, which was conceived by UCLA faculty and is conducted in collaboration with the American Heart Association/American Stroke Association.

The findings of the study are published in the April 23 issue of JAMA, the Journal of the American Medical Association.

The researchers report that at participating hospitals, the average time it took to deliver tPA to patients fell from 74 minutes to 59 minutes. This speedier treatment, they said, was accompanied by improved outcomes, including reduced mortality, fewer treatment complications and a greater likelihood that patients would go home after leaving the hospital instead of being referred to a skilled nursing facility for advanced rehabilitation.

"These findings reinforce the importance and clinical benefits of faster administration of intravenous tPA. Through this national initiative, more patients were able to be treated with this beneficial therapy and in a safer, more effective fashion," said first author Dr. Gregg C. Fonarow, UCLA's Eliot Corday Professor of Cardiovascular Medicine and Science and director of the Ahmanson-UCLA Cardiomyopathy Center at the David Geffen School of Medicine at UCLA.

The benefits of tPA in acute ischemic stroke are highly time-dependent, and for more than a decade, guidelines have recommended administering the treatment within 60 minutes of hospital arrival. Yet despite the evidence, recommendations and prior efforts, a previous study by the team found that less than 30 percent of eligible patients were receiving the medication in that first hour.

"Target: Stroke" was launched in 2010 to address this gap. The initiative provides 10 key "best practice" strategies to facilitate timely tPA administration, including earlier notification to hospitals from emergency services in the field that a stroke victim is on the way; rapidly conducting and interpreting CT scans at the hospital to identify candidates for tPA; pre-mixing tPA medication for high-likelihood candidates; and other specific protocols and other tools.

For the current study, researchers analyzed data on 71,169 stroke patients treated with tPA at 1,030 hospitals participating in "Target: Stroke." They compared time-to-treatment and the incidence of complications before the initiative launched (2003-09) and after its implementation (2010-13).

They found that in addition to the previously noted 15-minute reduction in average time-to-treatment (from 74 to 59 minutes), the percentage of patients treated within the recommended time frame increased from less than one-third to more than one-half. Further, before the initiative, 9.9 percent of patients died in the hospital; after its implementation, that fell to 8.3 percent -- a statistically significant change, the researchers said

The team also found that patients treated using the initiative's strategies were less likely to develop bleeding within the brain, which can be a complication of tPA treatment in certain types of strokes. "Target: Stroke" stresses that patients should undergo a CT scan upon arrrival at the hospital, before the administration of tPA, to determine the risk of such bleeding.

Many factors need to line-up to ensure quick, effective and safe stroke treatment, said study co-author Dr. Jeffrey L. Saver, a professor of neurology and director of the Comprehensive Stroke Center at the David Geffen School of Medicine at UCLA.

"Time lost is brain lost in acute stroke," Saver said. "A key message of this study is that the 'Target: Stroke' program enables hospitals to speed tPA treatment and improve patient outcomes. We hope that more U.S. hospitals caring for acute stroke patients will join this innovative and highly effective program."

Researchers also found that more patients were able to be treated with tPA after the implementation of the initiative. Prior to the program, only 64.7 percent of eligible patients were treated with tPA. After initiation of "Target: Stroke," this increased to 85.2 percent, said

Fonarow, a member of the American Heart Association/American Stroke Association's "Target: Stroke" committee.

Fonarow noted that treatment improvement was seen in all study patients. The median age of patients, who were evenly distributed between males and females, was 72. Almost three-quarters were white, 14 percent were black and 6 percent Hispanic.

"Target: Stroke" also helped improve patients' independence. After initiation of the program, more patients maintained the ability to walk without assistance. Also, 42.7 percent were able to go home after leaving the hospital rather than being referred to a skilled nursing facility, compared 37.6 percent before the initiative.

Currently, more than 1,500 hospitals in the U.S. are participating in the program. Researchers note that no previous initiative for improving timeliness of tPA treatment for acute ischemic stroke has had the size, scope, depth or clinical impact of "Target: Stroke."

Fonarow adds that these improvements in care, patient safety and clinical outcomes were able to be achieved on an entirely volunteer basis, with little to no extra cost among participating hospitals.

A second program is scheduled to be launched soon, "Target: Stroke Phase II," which aims to further improve the speed with which tPA is administered. The team will identify additional best-practice strategies and assess which patient, hospital and system factors account for the greatest improvement in timely treatment for acute ischemic stroke.

Saver adds that another key to effective treatment is identifying the onset of stroke. He suggests being aware of four stroke warning signs that can be easily remembered with the acronym FAST: (F)ace: Ask the person to smile. Does one side of the face droop? (A)rms: Ask the person to raise both arms. Does one arm drift downward? (S)peech: Ask the person to repeat a simple phrase. Is their speech slurred or strange? (T)ime: If you observe any of these signs, call 9-1-1 immediately.

More From ScienceDaily

More Mind & Brain News

Featured Research

Mar. 3, 2015 — No significant change in home habits of smokers have been observed in the aftermath of a ban on smoking in public spaces, researchers report. Greater inspiration to kick the habit likely comes from ... full story

Mar. 3, 2015 — Heart function has been associated with the development of dementia and Alzheimer's disease through a new study. Participants with decreased heart function, measured by cardiac index, were two to ... full story

Mar. 3, 2015 — Children of recently separated or divorced families are likelier to drink sugar-sweetened beverages than children in families where the parents are married, putting them at higher risk for obesity ... full story

Mar. 3, 2015 — Although sedatives are often administered before surgery, a randomized trial finds that among patients undergoing elective surgery under general anesthesia, receiving the sedative lorazepam before ... full story

Mar. 3, 2015 — Why do people shake hands? A new study suggests one of the reasons for this ancient custom may be to check out each other's odors. Even if we are not consciously aware of this, handshaking may ... full story

Mar. 3, 2015 — It appears that stress markers in unemployed people can be found, independent of smoking, alcohol consumption and overweight/obesity. Results from a study suggest that long-term unemployment may be ... full story

Mar. 3, 2015 — On the heels of an American nationwide measles outbreak comes a report that campaigns aimed at scaring people about the consequences of non-vaccination might not be as effective as many think. ... full story

Mar. 3, 2015 — Doctors write millions of prescriptions a year for drugs to calm the behavior of people with Alzheimer’s disease and other types of dementia. But non-drug approaches actually work better, and carry ... full story

Mar. 3, 2015 — Briefly counseling college students on the dangers of binge drinking is effective in lowering heavy drinking levels among many students, but only temporarily. Three out of four will be right back ... full story

Mar. 3, 2015 — Loneliness brought about by the death of a spouse can trigger a wider network of depression-like symptoms, a study has found, but authors suggest that doctors are often too quick to attribute these ... full story

Related Stories

Mar. 13, 2014 — Every 15-minute delay in delivering a clot-busting drug after stroke robs survivors of an average month of healthy life. Streamlining the time from symptom onset to clot-busting treatment by just one ... full story

Aug. 22, 2013 — In the case of mild or moderate strokes, getting treatment ultra-fast – within 90 minutes of experiencing symptoms – greatly reduces the risk of suffering disability, according to a new ... full story

Mar. 26, 2013 — Stroke patients are three times more likely to receive clot-busting medication if they're treated at a hospital certified as a primary stroke center. There is a limited window of opportunity for ... full story

Feb. 10, 2011 — Less than one-third of stroke patients treated with tissue plasminogen activator (tPA) received the clot-busting drug within 60 minutes or less of their arrival. A hospital arrival-to-treatment ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.